Oramed Pharmaceuticals

ORMP

Börsenwert 166 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	BCM 1 BML Capital Management Zionsville, Indiana	9,03 Mio. $	–	–	–
2	GIA 2 Gem Investment Advisors Teaneck, New Jersey	5,7 Mio. $	+5,16 Mio. $	+1.998.802	Neu
3	3 Aquamarine Financial George Town,	5,62 Mio. $	–	–	–
4	4 SB Capital Management Encino, California	5,42 Mio. $	+4,9 Mio. $	+1.900.000	Neu
5	5 Murchinson Toronto, Ontario, Canada	3,82 Mio. $	-1,06 Mio. $	-411.312	-23 %
6	6 Boothbay Fund Management New York	1,74 Mio. $	-601.549 $	-233.231	-28 %
7	7 Marshall Wace London, United Kingdom	738.308 $	+668.155 $	+259.055	Neu
8	8 Rathbones Group Liverpool, United Kingdom	664.101 $	–	–	–
9	9 Citadel Advisors Miami, Florida	558.657 $	+217.460 $	+84.313	+75 %
10	10 Dimensional Fund Advisors Austin, Texas	428.843 $	+7.696 $	+2.984	+2 %
11	11 Renaissance Technologies New York	420.375 $	-3.611 $	-1.400	-0,9 %
12	12 Bank of America Charlotte, North Carolina	405.393 $	-19.148 $	-7.424	-5 %
13	13 Wells Fargo San Francisco, California	372.169 $	+1.290 $	+500	+0,4 %
14	14 BlackRock New York	257.104 $	-50.349 $	-19.521	-18 %
15	15 Jane Street New York	223.038 $	+47.973 $	+18.600	+31 %
16	16 Squarepoint New York	166.075 $	+73.265 $	+28.406	+95 %
17	17 HRT Financial New York	131.000 $	+118.878 $	+46.091	Neu
18	18 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	124.645 $	+39.957 $	+15.492	+55 %
19	19 RBF Capital San Francisco, California	122.399 $	–	–	–
20	20 Quadrature Capital London, United Kingdom	118.942 $	+107.640 $	+41.734	Neu
21	21 XTX Topco George Town, Cayman Islands	108.819 $	+36.875 $	+14.297	+60 %
22	22 Susquehanna International Group Bala Cynwyd, Pennsylvania	74.054 $	-27.961 $	-10.841	-29 %
23	23 Point72 Asset Management Stamford, Connecticut	72.510 $	+65.620 $	+25.442	Neu
24	24 Geode Capital Management Boston, Massachusetts	69.203 $	–	–	–
25	25 Two Sigma Securities New York	65.958 $	+59.690 $	+23.143	Neu

Oramed Pharmaceuticals ORMP Börsenwert 166 Mio. $

Oramed Pharmaceuticals

ORMP

Börsenwert 166 Mio. $